# Disease Evolution Prediction
Temporal Data for State-Transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid Leukemia (Mouse)

Shared drive: https://drive.google.com/drive/folders/1TBw_nIOSyVElKF9zGMJ6CWXd1ehQs6ok


# Research Summary: State-transition Modeling of Blood Transcriptome in CML

## Study Overview
**Title:** State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid Leukemia (CML)

**Organism:** *Mus musculus* (Mouse)

**Technology:** Expression profiling by high throughput sequencing

**Publication Status:** Public since November 2, 2023

---

## Research Objective
This study tests the hypothesis that **transcriptome-based state-transition models** can accurately predict cancer evolution and treatment response in Chronic Myeloid Leukemia.

---

## Experimental Design

### Mouse Cohorts & Group Mapping
| TET Status Group | Experimental Group | Sample Size | Description |
|------------------|-------------------|-------------|-------------|
| TET_OFF_ON | Group A | n=4 | TOTO cohort - Disease development followed by suppression (ideal treatment scenario) |
| TET_OFF | Group B | n=6 | Induced disease mimicking human chronic phase CML|
| TET_ON | Group C | n=3 | BCR-ABL(Lukemia Genes) suppressed |
| TET_OFF_NIL_ON | Group D | n=7 | TKI cohort - Clinical simulation with 4-week nilotinib treatment window |

### Mouse Identifiers
- **Group A**: 476, 482, 483, 545
- **Group B**: 480, 541, 484, 477, 487, 542
- **Group C**: 489, 490, 488
- **Group D**: 502, 512, 507, 508, 514, 511, 513


